益生菌、益生元、合生元：炎症性肠病的生态疗法？
Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?
作者信息
Marteau P
出版信息
Gut. 2006 Dec;55(12):1692-3. doi: 10.1136/gut.2004.051458.
Abstract
Ecological treatment may be beneficial in patients with ulcerative colitis
摘要
生态疗法可能对溃疡性结肠炎患者有益。
相似文献
1
Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?益生菌、益生元、合生元：炎症性肠病的生态疗法？
Gut. 2006 Dec;55(12):1692-3. doi: 10.1136/gut.2004.051458.
2
Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?对于炎症性肠病患者，食用益生菌、益生元或合生元有任何作用吗？
Mol Nutr Food Res. 2008 Aug;52(8):906-12. doi: 10.1002/mnfr.200700147.
3
Prebiotics, synbiotics and inflammatory bowel disease.益生元、合生元与炎症性肠病
Mol Nutr Food Res. 2008 Aug;52(8):898-905. doi: 10.1002/mnfr.200700139.
4
Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.益生菌和益生元在炎症性肠病中应用的证据：一项临床试验综述
Proc Nutr Soc. 2007 Aug;66(3):307-15. doi: 10.1017/S0029665107005563.
5
[Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].[肠道菌群在炎症性肠病中的作用及益生菌在其治疗中的地位]
Tunis Med. 2005 Mar;83(3):132-6.
6
Clinical usefulness of probiotics in inflammatory bowel diseases.益生菌在炎症性肠病中的临床应用价值
J Physiol Pharmacol. 2006 Nov;57 Suppl 9:23-33.
7
Clinical utility of probiotics in inflammatory bowel disease.益生菌在炎症性肠病中的临床应用价值
Altern Ther Health Med. 2011 Jan-Feb;17(1):72-9.
8
Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis.探讨益生菌、益生元和合生菌的潜力：溃疡性结肠炎治疗的新进展。
Front Cell Infect Microbiol. 2023 Dec 8;13:1268041. doi: 10.3389/fcimb.2023.1268041. eCollection 2023.
9
Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.肠道微生物群：炎症性肠病治疗方法的新靶点。
Expert Opin Ther Targets. 2008 Mar;12(3):301-12. doi: 10.1517/14728222.12.3.301.
10
Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.益生菌、益生元、合生元和精神益生菌在炎症性肠病中的有益作用。
Inflamm Bowel Dis. 2015 Jul;21(7):1674-82. doi: 10.1097/MIB.0000000000000364.
引用本文的文献
1
Antibiotic-Induced Dysbiosis of Gut Microbiota Impairs Corneal Nerve Regeneration by Affecting CCR2-Negative Macrophage Distribution.抗生素诱导的肠道微生物失调通过影响 CCR2-阴性巨噬细胞分布来损害角膜神经再生。
Am J Pathol. 2018 Dec;188(12):2786-2799. doi: 10.1016/j.ajpath.2018.08.009.
2
Asthma Prevention by Lactobacillus Rhamnosus in a Mouse Model is Associated With CD4(+)CD25(+)Foxp3(+) T Cells.罗伊氏乳杆菌预防小鼠哮喘与其诱导 CD4(+)CD25(+)Foxp3(+)T 细胞有关。
Allergy Asthma Immunol Res. 2012 May;4(3):150-6. doi: 10.4168/aair.2012.4.3.150. Epub 2012 Feb 8.
3
Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum".用于炎症性肠病肠道不适症状的碳水化合物排除或适应性饮食：“吉布森难题”的原理
Int J Inflam. 2012;2012:493717. doi: 10.1155/2012/493717. Epub 2012 Feb 29.
4
Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders.益生菌给药可诱导调节性树突状细胞和 CD4+Foxp3+T 细胞的产生，从而抑制免疫紊乱。
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2159-64. doi: 10.1073/pnas.0904055107. Epub 2010 Jan 13.
5
Butyrate-induced transcriptional changes in human colonic mucosa.丁酸盐诱导的人结肠黏膜转录变化。
PLoS One. 2009 Aug 25;4(8):e6759. doi: 10.1371/journal.pone.0006759.
本文引用的文献
1
Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial.合生制剂疗法（长双歧杆菌/合生元1）可促使活动期溃疡性结肠炎患者的炎症消退：一项随机对照试验。
Gut. 2005 Feb;54(2):242-9. doi: 10.1136/gut.2004.044834.
2
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.使用益生菌大肠杆菌Nissle 1917维持溃疡性结肠炎缓解的效果与使用标准美沙拉嗪相当。
Gut. 2004 Nov;53(11):1617-23. doi: 10.1136/gut.2003.037747.
3
NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.大肠杆菌Nissle 1917通过NF-κB和AP-1介导诱导肠上皮细胞中人β-防御素-2：一种益生菌的新作用
Infect Immun. 2004 Oct;72(10):5750-8. doi: 10.1128/IAI.72.10.5750-5758.2004.
4
Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice.通过基因改造的乳酸乳球菌主动递送三叶因子可预防和治愈小鼠的急性结肠炎。
Gastroenterology. 2004 Aug;127(2):502-13. doi: 10.1053/j.gastro.2004.05.020.
5
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.炎症性肠病中肠道微生物群的治疗性调控：抗生素、益生菌和益生元。
Gastroenterology. 2004 May;126(6):1620-33. doi: 10.1053/j.gastro.2004.03.024.
6
Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats.给HLA - B27转基因大鼠喂食含菊粉的益生菌制剂（SIM）对结肠炎严重程度及肠道微生物群组成的影响。
Clin Diagn Lab Immunol. 2004 May;11(3):581-7. doi: 10.1128/CDLI.11.3.581-587.2004.
7
Probiotics in inflammatory bowel disease: is it all gut flora modulation?炎症性肠病中的益生菌：全都是肠道菌群调节作用吗？
Gut. 2004 May;53(5):620-2. doi: 10.1136/gut.2003.034249.
8
9
Nitric oxide released by Lactobacillus farciminis improves TNBS-induced colitis in rats.发酵乳杆菌释放的一氧化氮可改善三硝基苯磺酸诱导的大鼠结肠炎。
Scand J Gastroenterol. 2004 Jan;39(1):37-45. doi: 10.1080/00365520310007152.
10
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.每日一次高剂量益生菌疗法（VSL#3）用于维持复发性或难治性袋炎的缓解。
Gut. 2004 Jan;53(1):108-14. doi: 10.1136/gut.53.1.108.
Zotero 插件